Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)

HKG:8217 Revenue

Ju Fu Tang Biotech Holdings had revenue of 17.31M HKD in the half year ending September 30, 2025, a decrease of -15.68%. This brings the company's revenue in the last twelve months to 27.51M, down -32.25% year-over-year. In the fiscal year ending March 31, 2025, Ju Fu Tang Biotech Holdings had annual revenue of 36.20M with 3.02% growth.

• Revenue (ttm): 27.51M
• Revenue Growth: -32.25%
• P/S Ratio: 4.17
• Revenue / Employee: 1.25M
• Employees: 22
• Market Cap: 114.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	36.20M	1.06M	3.02%
Mar 31, 2024	35.14M	-69.46M	-66.40%
Mar 31, 2023	104.60M	11.85M	12.77%
Mar 31, 2022	92.75M	-75.55M	-44.89%
Mar 31, 2021	168.30M	-186.58M	-52.58%